Berberol®: New Review Confirms Its Potential for Managing Glycemic Control and Insulin Resistance
Berberol®, a nutraceutical combining Berberis aristata and Silybum marianum, has shown promise in improving glycemic control and reducing insulin resistance.
A recent meta-analysis highlights its effectiveness in lowering blood glucose and HbA1c levels, thanks to the synergistic action between berberine and silymarin. Berberol® is effective both as a standalone and adjunctive therapy, offering a valuable option for managing glycemic issues.